Cardiology Letters 2013, 22(1):28-31
Renal denervation in resistant hypertension: revolution in therapy or blind alley?
- 1 Kardiocentrum 3. Lékařské fakulta Univerzita Karlovy v Praze
- 2 III. Interní klinika 1. Lékařské fakulta Univerzita Karlovy v Praze, Česká republika
The article takes an overview of the collected facts regarding prospective methods for the treatment of resistant hypertension: cathether-based renal denervation. Futher the PRAGUE 15 design study is presented and the current position of renal denervation in cardiology is discused.
Keywords: renal denervation; ablation; resistant hypertension; arteria renalis
Published: January 1, 2013 Show citation
References
- Cífková R, Škodová Z, Bruthans J, Adamková V, Jozifová M, Galovcová M, Wohlfahrt P, Krajcoviechova A, Poledne R, Stavek P, Lanska V. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 2010;211(2):676-681.
Go to original source... - Štrauch B. Arteriální hypertenze a compliance k léčbě. In: Widimský jr. J, ed. Arteriální hypertenze - současné klinické trendy X. Praha: Triton; 2012:25-31.
- Pikus T, Widimský jr. J, Zelinka T, Rosa J, Štrauch B, Petrák O, Holaj R. Prevalence and clinical characteristics of resistant hypertension in a specialist center. Cor Vasa. 2007;49(10):351-354. Go to original source...
- Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O'Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635-1642. Go to original source...
- Kaplan NM. Resistant hypertension. J Hypertens. 2005;23(8):14411444. Go to original source...
- Vidt DG. Contributing factors in resistant hypertension. Truly refractory disease is rarely found in a properly conducted workup. Postgrad Med. 2000;107(5):57-60, 63-54, 67-58, 70. Go to original source...
- Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet. 1953;1(6757):403-408. Go to original source...
- Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361(9):932-934. Go to original source...
- Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):19031909. Go to original source...
- Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-ofprinciple cohort study. Lancet. 2009;373(9671):1275-1281. Go to original source...
- Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911-917.
- Widimsky P, Filipovsky J, Widimsky J jr., Branny M, Monhart V, Taborsky M. Expert consensus statement of the Czech Society of Cardiology and the Czech Society of Hypertension on catheterbased sympathetic renal denervation procedures (RDN) in the Czech Republic. Cor Vasa 2012;54: e108-e112. Go to original source...